Author

Ioannis Kagiampakis

Observed names: I. Kagiampakis, Kagiampakis, Ioannis

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States)

Observed institutions: AstraZeneca (United Kingdom), University of the Pacific, United States Department of Energy, Johns Hopkins University, University of California, Merced, The University of Texas at San Antonio Health Science Center, University of Michigan, Johns Hopkins Medicine, Frederick National Laboratory for Cancer Research, National Cancer Institute, AstraZeneca (Canada), Center for Cancer Research, AstraZeneca (United States), Sidney Kimmel Comprehensive Cancer Center, Rice University, Texas A&M University

OpenAlex ID: A5010395260

Sorghum bicolor’s Transcriptome Response to Dehydration, High Salinity and ABA

2005 · Christina D. Buchanan, Sanghyun Lim, et al. · Plant Molecular Biology · 307

Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations

2017 · Michelle Vaz, Stephen Y. Hwang, et al. · Cancer Cell · 191

PDF

DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk

2018 · Wenbing Xie, Ioannis Kagiampakis, et al. · Cancer Cell · 121

PDF

Triggering of RNA Interference with RNA–RNA, RNA–DNA, and DNA–RNA Nanoparticles

2014 · Kirill A. Afonin, Mathias Viard, et al. · ACS Nano · 116

Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines

2018 · Eniko Papp, Dorothy Hallberg, et al. · Cell Reports · 97

PDF

Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth

2017 · Yuan Liu, Tracy Murray-Stewart, et al. · International Journal of Oncology · 69

A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine

2017 · Benjamin R. Leadem, Ioannis Kagiampakis, et al. · Cancer Research · 62

Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma

2020 · Shaji K. Kumar, Magdalini Migkou, et al. · Blood · 57

Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications

2015 · Kshitij Gupta, Kirill A. Afonin, et al. · Journal of Controlled Release · 47

The Griffithsin Dimer Is Required for High-Potency Inhibition of HIV-1: Evidence for Manipulation of the Structure of gp120 as Part of the Griffithsin Dimer Mechanism

2013 · Jie Xue, Bart Hoorelbeke, et al. · Antimicrobial Agents and Chemotherapy · 47

PDF

The Role of Individual Carbohydrate-Binding Sites in the Function of the Potent Anti-HIV Lectin Griffithsin

2012 · Jie Xue, Yongguang Gao, et al. · Molecular Pharmaceutics · 46

PDF

Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy

2024 · Tafadzwa L. Chaunzwa, Jack M. Qian, et al. · JAMA Oncology · 43

Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers

2025 · Gustavo Arango-Argoty, Elly Kipkogei, et al. · Nature Communications · 34

Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41

2010 · Ioannis Kagiampakis, Arbi Gharibi, et al. · Antimicrobial Agents and Chemotherapy · 31

HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation

2019 · Philip R. Tedbury, Mariia Novikova, et al. · Journal of Virology · 28

Structural and functional studies of the potent anti‐HIV chemokine variant P2‐RANTES

2009 · Hongjun Jin, Ioannis Kagiampakis, et al. · Proteins Structure Function and Bioinformatics · 17

Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non–small-cell lung cancer

2024 · Chao Fang, Gustavo Alonso Arango Argoty, et al. · Journal of Translational Medicine · 16

Explainable Transformer-Based Neural Network for the Prediction of Survival Outcomes in Non-Small Cell Lung Cancer (NSCLC)

2021 · Elly Kipkogei, Gustavo Alonso Arango Argoty, et al. · medRxiv · 15

PDF

ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study

2024 · Michael Maris, Gilles Salles, et al. · Targeted Oncology · 13

PDF

Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma

2024 · Meletios A. Dimopoulos, Magdalini Migkou, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11

Nickel-Dependent Oligomerization of the Alpha Subunit of Acetyl-Coenzyme A Synthase/Carbon Monoxide Dehydrogenase

2007 · Xiangshi Tan, Ioannis Kagiampakis, et al. · Biochemistry · 11

Conservation of Unfavorable Sequence Motifs That Contribute to the Chemokine Quaternary State

2008 · Ioannis Kagiampakis, Hongjun Jin, et al. · Biochemistry · 4

An Information Measure of the Quality of Protein Secondary Structure Prediction

2008 · Rosemarie Swanson, Ioannis Kagiampakis, et al. · Journal of Computational Biology · 3

Atopic Dermatitis Biomarker Analysis Points to Elevation of TSLP and IL-33 Signaling and Suggests a Role for Type 2 Innate Lymphoid Cells

2020 · Janet Griffiths, Sriram Sridhar, et al. · Journal of Allergy and Clinical Immunology · 2

PDF

Detecting protein dissimilarities in multiple alignments using Bayesian variable selection

2006 · Sinae Kim, Jerry Tsai, et al. · Bioinformatics · 2

PDF

Works count: 57

Citation count: 1,394

H-index: 16

I10-index: 21